KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPension (IS)Profit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Colgate Palmolive (CL) EBT (2016 - 2025)

Colgate Palmolive (CL) has 17 years of EBT data on record, last reported at $108.0 million in Q4 2025.

  • For Q4 2025, EBT fell 89.12% year-over-year to $108.0 million; the TTM value through Dec 2025 reached $3.1 billion, down 22.67%, while the annual FY2025 figure was $3.1 billion, 22.67% down from the prior year.
  • EBT reached $108.0 million in Q4 2025 per CL's latest filing, down from $991.0 million in the prior quarter.
  • Across five years, EBT topped out at $1.0 billion in Q2 2024 and bottomed at $108.0 million in Q4 2025.
  • Average EBT over 5 years is $807.7 million, with a median of $953.0 million recorded in 2021.
  • Peak YoY movement for EBT: soared 648.48% in 2023, then tumbled 89.12% in 2025.
  • A 5-year view of EBT shows it stood at $324.0 million in 2021, then plummeted by 59.26% to $132.0 million in 2022, then skyrocketed by 648.48% to $988.0 million in 2023, then increased by 0.51% to $993.0 million in 2024, then crashed by 89.12% to $108.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $108.0 million in Q4 2025, $991.0 million in Q3 2025, and $1.0 billion in Q2 2025.